发布求助
文献互助 智能选刊 最新文献

Cancer Therapy & Oncology International Journal最新文献

筛选
英文 中文
Liver Metastasis as the First Manifestation of Occult Breast Carcinoma 肝转移是隐匿性乳腺癌的第一表现
Cancer Therapy & Oncology International Journal Pub Date : 2022-01-07 DOI: 10.19080/ctoij.2022.20.556040
Welington Lombardi
{"title":"Liver Metastasis as the First Manifestation of Occult Breast Carcinoma","authors":"Welington Lombardi","doi":"10.19080/ctoij.2022.20.556040","DOIUrl":"https://doi.org/10.19080/ctoij.2022.20.556040","url":null,"abstract":"","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115266306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteoclastoma-Like Giant Cell Tumour of the Liver – First Reported Case from Kuwait 肝类破骨细胞瘤巨细胞瘤-科威特首例报道
Cancer Therapy & Oncology International Journal Pub Date : 2022-01-04 DOI: 10.19080/ctoij.2022.20.556039
A. Mohanty
{"title":"Osteoclastoma-Like Giant Cell Tumour of the Liver – First Reported Case from Kuwait","authors":"A. Mohanty","doi":"10.19080/ctoij.2022.20.556039","DOIUrl":"https://doi.org/10.19080/ctoij.2022.20.556039","url":null,"abstract":"","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"181 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121587492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Ovarian Cancer and Its Correlation with Age in Pakistan 巴基斯坦卵巢癌患病率及其与年龄的关系
Cancer Therapy & Oncology International Journal Pub Date : 2021-12-27 DOI: 10.19080/ctoij.2021.20.556038
M. Mazhar
{"title":"Prevalence of Ovarian Cancer and Its Correlation with Age in Pakistan","authors":"M. Mazhar","doi":"10.19080/ctoij.2021.20.556038","DOIUrl":"https://doi.org/10.19080/ctoij.2021.20.556038","url":null,"abstract":"A group of diseases that originate from the different parts of ovaries and cause production of abnormal cells that divide uncontrolled themselves in the ovaries is known as ovarian cancer. OC is mainly classified into majorly three types on the base of three components of ovaries known as epithelium, stroma and germinal cells. Approximately, 7000 women develop OC and 4200 of them die every year in the UK. In Pakistan, the incidence of OC is increasing at the rate of around 13.6%. Approximately 70% cases are diagnosed at later stages. The blood sample was collected in the Layyah region. The CA125 identification through Elisa technique for their better identification on the basis of antibodies. Normal values of CA125 were considered less than 35 U/ml. The other tumor markers were also measured such as fibrinogen, prolactin, CA15.3, PT, APTT, INR, D Dimer, and CA19.9. The mean age of patients was 59.0 ± 8.1while the minimum and maximum age at which the tumor marker detection was 22 and 74 years. The number of patients was found in order of 25 >24 > 10 in 1st,2nd and 3rd age groups, respectively. The clinical histopathological test in the ovarian cancer patients show that the tumor size 5.21±3.42, fibrinogen 5.09±1.29, CA-199 (U/mL) 121.17±59.76, and D-dimer 0.61±0.31. The CA-125 level increase in ovarian cancer patients is indicated as a tumor marker.","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"68 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130255231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Horizons and Challenges of Cancer Therapy 癌症治疗的新视野和挑战
Cancer Therapy & Oncology International Journal Pub Date : 2021-12-15 DOI: 10.19080/ctoij.2021.20.556037
M. Tan
{"title":"New Horizons and Challenges of Cancer Therapy","authors":"M. Tan","doi":"10.19080/ctoij.2021.20.556037","DOIUrl":"https://doi.org/10.19080/ctoij.2021.20.556037","url":null,"abstract":"Cancer is one of the top causes of death, and a huge barrier for high-quality life globally [1]. In 2020 alone, there were 19.3 million new cases, of which close to 10 million were fatal [2]. It is estimated that cancer-related healthcare costs would amount to $232.9 billion between 2020 and 2030 [3]. Therefore, it is imperative to develop new and improved medicines for cancer therapy to enhance the patients’ quality of life lower the mortality rates. Currently, an increasing number of prospective medicines and novel therapies are being tested in clinical trials, some of which have benefited the enrolled patients. Here, we will review the eve and challenges of cancer therapy, with particular focus on immunotherapy and targeted therapy.","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126828748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer and Virtual Reality VR, the Great Challenge of the Century 癌症和虚拟现实VR，世纪的重大挑战
Cancer Therapy & Oncology International Journal Pub Date : 2021-12-10 DOI: 10.19080/ctoij.2021.20.556036
Sakhri Selma
{"title":"Cancer and Virtual Reality VR, the Great Challenge of the Century","authors":"Sakhri Selma","doi":"10.19080/ctoij.2021.20.556036","DOIUrl":"https://doi.org/10.19080/ctoij.2021.20.556036","url":null,"abstract":"","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132754683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 and Cytokine Storm COVID-19和细胞因子风暴
Cancer Therapy & Oncology International Journal Pub Date : 2021-12-07 DOI: 10.19080/ctoij.2021.20.556035
N. Hamed
{"title":"COVID-19 and Cytokine Storm","authors":"N. Hamed","doi":"10.19080/ctoij.2021.20.556035","DOIUrl":"https://doi.org/10.19080/ctoij.2021.20.556035","url":null,"abstract":"","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115620238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Secretory Sanguine- Middle Ear Paraganglioma 分泌血-中耳副神经节瘤
Cancer Therapy & Oncology International Journal Pub Date : 2021-12-01 DOI: 10.19080/ctoij.2021.20.556034
{"title":"The Secretory Sanguine- Middle Ear Paraganglioma","authors":"","doi":"10.19080/ctoij.2021.20.556034","DOIUrl":"https://doi.org/10.19080/ctoij.2021.20.556034","url":null,"abstract":"","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131187475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical Fibroxanthoma of the Eyelid - Surgical Resolution and Unexpected Complication, a Case Report 眼睑非典型纤维黄色瘤手术治疗及意外并发症1例报告
Cancer Therapy & Oncology International Journal Pub Date : 2021-11-12 DOI: 10.19080/ctoij.2021.20.556032
Martín González
{"title":"Atypical Fibroxanthoma of the Eyelid - Surgical Resolution and Unexpected Complication, a Case Report","authors":"Martín González","doi":"10.19080/ctoij.2021.20.556032","DOIUrl":"https://doi.org/10.19080/ctoij.2021.20.556032","url":null,"abstract":"","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"238 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131668222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of three Diagnostic Methods of Real time PCR, Reverse Dot Blot and DNA Sequencing for Analysis of KRAS Mutations in Patients with Colorectal Cancer 实时PCR、反向Dot Blot和DNA测序三种诊断方法分析结直肠癌患者KRAS突变的比较
Cancer Therapy & Oncology International Journal Pub Date : 2021-11-08 DOI: 10.19080/ctoij.2021.20.556031
N. Nouri
{"title":"Comparison of three Diagnostic Methods of Real time PCR, Reverse Dot Blot and DNA Sequencing for Analysis of KRAS Mutations in Patients with Colorectal Cancer","authors":"N. Nouri","doi":"10.19080/ctoij.2021.20.556031","DOIUrl":"https://doi.org/10.19080/ctoij.2021.20.556031","url":null,"abstract":"","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131567503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strychnine, a Natural Alkaloid, induces Liver Cancer cells Apoptosis and G0/G1-Phase Arrest through IL-6/JAK2/Stat3 Signaling Pathway 天然生物碱士的宁通过IL-6/JAK2/Stat3信号通路诱导肝癌细胞凋亡和G0/ g1期阻滞
Cancer Therapy & Oncology International Journal Pub Date : 2021-10-27 DOI: 10.19080/ctoij.2021.20.556029
Jiewen Guo
{"title":"Strychnine, a Natural Alkaloid, induces Liver Cancer cells Apoptosis and G0/G1-Phase Arrest through IL-6/JAK2/Stat3 Signaling Pathway","authors":"Jiewen Guo","doi":"10.19080/ctoij.2021.20.556029","DOIUrl":"https://doi.org/10.19080/ctoij.2021.20.556029","url":null,"abstract":"","PeriodicalId":360247,"journal":{"name":"Cancer Therapy & Oncology International Journal","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126099183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信